| PBQAX | RGAHX | PBQAX / RGAHX | |
| Total Expense Ratio | 0.91 | 0.44 | 207% |
| Annual Report Gross Expense Ratio | 0.91 | 0.44 | 207% |
| Fund Existence | 36 years | 11 years | - |
| Gain YTD | 13.806 | 7.244 | 191% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.18B | 357B | 0% |
| Annual Yield % from dividends | 0.04 | 0.40 | 9% |
| Returns for 1 year | 12.94 | 4.43 | 292% |
| Returns for 3 years | 32.57 | 39.88 | 82% |
| Returns for 5 years | 3.55 | 16.49 | 22% |
| Returns for 10 years | 52.28 | 102.84 | 51% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FSEIX | 63.23 | N/A | N/A |
| Nuveen Mid Cap Value Opportunities I | |||
| FIKCX | 72.53 | N/A | N/A |
| Fidelity Advisor Health Care Z | |||
| VADGX | 32.27 | N/A | N/A |
| Vanguard Advice Select Dividend Gr Admrl | |||
| FBPGX | 29.15 | N/A | N/A |
| Cantor Fitzgerald Equity Dividend Plus A | |||
| PAMCX | 94.34 | N/A | N/A |
| T. Rowe Price Mid-Cap Growth Adv | |||